regulatory update: three fda approvals and two priority reviews

Published 8 years ago • 262 plays • Length 8:22

Download video MP4
Download video MP3

Similar videos

8:45

fda approvals in gvhd, crc, and aml, a priority review in mcl, and more
6:02

fda approvals, breakthrough designations, priority reviews, and more
6:24

fda approval and priority review in ovarian cancer, end of part b payment model, and more
5:32

fda approval and 2 priority reviews in bladder cancer, and asco's cancer advance of the year
8:48

fda approval in aml, priority review designation in nsclc, and more
4:12

jadual bayaran str fasa 3 mengikut bank penerima [r5]
13:56

regulatory affairs explained series episode 3 | common documents, forms, clinicaltrials.gov & more
4:12

jadual bayaran str fasa 3 mengikut bank penerima [r4]
11:50

fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
9:54

fda approval in nsclc, priority review designation in sclc, crl to biosimilar, and more
12:16

conference highlights, three fda approvals, and more
10:55

fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
18:10

sbia program overview - redi 2020
7:27

fda approval for vod, nda for carcinoid syndrome, european regulatory advancements, and more
10:29

fda approval in melanoma, priority review in dlbcl, rcc, and ntrk fusion–positive tumors
0:31

preview: fda approval and priority review in ovarian cancer, end of part b payment model, and more
7:07

fda approval in crc, priority review in hcc, encouraging data in myeloma trial, and more
9:02

fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
9:40

fda approval in nsclc, priority reviews, and 2016 elcc highlights
8:21

fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
8:07

fda approval in lung cancer, priority reviews in hcc and nhl, and an odac recommendation
2:43

fda programs - breakthrough | fast track | accelerated approval | priority review

Clip.africa.com - Privacy-policy